Nima Farzan

This profile gathers the share dealings of Nima Farzan across 2 companies, led by Keros Therapeutics, Inc. and Kinnate Biopharma Inc. In total, 3 filings cover trades dated from 3 April 2024 to 4 June 2026.

On the market, this insider has only sold: 1 sale, €24k in total. The rest of the record consists of 1 share grant. So far in 2026, the count stands at no purchases and 1 sale.

The latest filing, published on 8 June 2026, reports an open-market sale of €24k in Keros Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.